The Citizen Potawatomi Nation (CPN) in Shawnee, Oklahoma, is requesting $825,000 in federal funding for the CPN Tribal Opioid Response (TOR) program. The CPN TOR program, in coordination with local partners, will address the overdose crisis in the CPN Tribal community by increasing access to treatment, including Medication Assisted Treatment (MAT), and recovery support services to those suffering from Opioid Use Disorder (OUD) and co-occurring substance use disorders (SUD), including stimulant use disorders involving cocaine and methamphetamine. In addition, the CPN TOR program will reduce overdose deaths in the Tribal community through implementing and supporting harm reduction and prevention activities. American Indian/Alaskan Native (AI/AN) people and their families within the CPN tribal health and social services program area, regardless of their tribal affiliation, constitute the population of focus for this project. The service area of the Citizen Potawatomi Tribal Health Services (CPNHS) includes five counties located in central Oklahoma (Cleveland, Lincoln, Logan, Oklahoma, and Pottawatomie). CPHNS patients who present with OUD or stimulant use disorder involving methamphetamine or cocaine will have access to a comprehensive suite of culturally appropriate treatment services coordinated with MAT, inpatient and outpatient services, individual, group and family therapy, and recovery support services including sober living. The project will serve 24 unduplicated patients per year; 48 OUD patients will be served over the duration of the project period.
The CPN TOR project team will first develop a recovery-oriented, and equity-based Strategic Plan that will focus on improving the overall behavioral health of our Tribal community and CPNHS patients. The Strategic Plan will include the following goals and objectives: (1) Implement evidence-based prevention, treatment and recovery service delivery models to provide a full spectrum of treatment, including MAT, and recovery support services, such as recovery housing, to those suffering from OUD or stimulant use disorder. (2) Provide assistance to patients for treatment costs or reduce treatment costs for under and uninsured patients. (3) Develop culturally appropriate material for educational and prevention purposes. (4) Increase public awareness and education on opioid prevention, treatment and recovery practices. (5) Purchase and disseminate fentanyl test strips and the opioid overdose antidote, naloxone, and provide training on their use. (6) Implement workforce development activities and encourage practitioners to obtain Data waiver for prescribing buprenorphine for the treatment of OUD. (7) Assess the impact of the TOR program.
In 2019, the United Health Foundation/America’s Health Ranking Report determined Oklahoma’s AI/AN drug death rates due to drug injury of any intent per 100,000 population was 21.1, which was higher than the state average of 13.1 for all other races combined. Drug overdose death rates were the highest for AI/AN people during 2019 and 2020 and continue to increase. The CPN TOR project will reduce those rates by addressing gaps in treatment and recovery services for OUD patients, providing more access to MAT, and through strategic prevention and harm reduction efforts.